These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37813418)

  • 1. Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial.
    Liu L; Xie X; Pan Y; Wang A; Wei Y; Liu J; Nie X; Liu D; Zhao Z; Wang P; Shen S; Zhong C; Xu T; Wang D; Wang GC; Song D; Ma Y; Zhao J; Jiang Y; Jing J; Meng X; Obst K; Chen CS; Wang D; Wang Y; Zhang Y; Wang Y; He J;
    BMJ; 2023 Oct; 383():e076448. PubMed ID: 37813418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial.
    He J; Zhang Y; Xu T; Zhao Q; Wang D; Chen CS; Tong W; Liu C; Xu T; Ju Z; Peng Y; Peng H; Li Q; Geng D; Zhang J; Li D; Zhang F; Guo L; Sun Y; Wang X; Cui Y; Li Y; Ma D; Yang G; Gao Y; Yuan X; Bazzano LA; Chen J;
    JAMA; 2014 Feb; 311(5):479-89. PubMed ID: 24240777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
    Mazighi M; Richard S; Lapergue B; Sibon I; Gory B; Berge J; Consoli A; Labreuche J; Olivot JM; Broderick J; Duhamel A; Touze E; Qureshi AI; Yavchitz A; Escalard S; Desilles JP; Redjem H; Smajda S; Fahed R; Hébert S; Maïer B; Delvoye F; Boursin P; Maacha MB; Obadia M; Sabben C; Blanc R; Savatovsky J; Piotin M;
    Lancet Neurol; 2021 Apr; 20(4):265-274. PubMed ID: 33647246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
    Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
    Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Yang P; Song L; Zhang Y; Zhang X; Chen X; Li Y; Sun L; Wan Y; Billot L; Li Q; Ren X; Shen H; Zhang L; Li Z; Xing P; Zhang Y; Zhang P; Hua W; Shen F; Zhou Y; Tian B; Chen W; Han H; Zhang L; Xu C; Li T; Peng Y; Yue X; Chen S; Wen C; Wan S; Yin C; Wei M; Shu H; Nan G; Liu S; Liu W; Cai Y; Sui Y; Chen M; Zhou Y; Zuo Q; Dai D; Zhao R; Li Q; Huang Q; Xu Y; Deng B; Wu T; Lu J; Wang X; Parsons MW; Butcher K; Campbell B; Robinson TG; Goyal M; Dippel D; Roos Y; Majoie C; Wang L; Wang Y; Liu J; Anderson CS;
    Lancet; 2022 Nov; 400(10363):1585-1596. PubMed ID: 36341753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design.
    Liu L; Wang Y; Xie X; Liu D; Wang A; Wang P; Shen S; Zhong C; Wei Y; Xu T; Pan Y; Jiang Y; Meng X; Wang D; Zhang Y; He J; Wang Y
    Stroke Vasc Neurol; 2021 Jun; 6(2):286-290. PubMed ID: 33727409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.
    ENOS Trial Investigators
    Lancet; 2015 Feb; 385(9968):617-628. PubMed ID: 25465108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate Antihypertensive Treatment for Patients With Acute Ischemic Stroke With or Without History of Hypertension: A Secondary Analysis of the CATIS Randomized Clinical Trial.
    Zhang R; Zhong C; Zhang Y; Xie X; Zhu Z; Wang A; Chen CS; Peng Y; Peng H; Li Q; Ju Z; Geng D; Chen J; Liu L; Wang Y; Xu T; He J
    JAMA Netw Open; 2019 Jul; 2(7):e198103. PubMed ID: 31365109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial.
    van den Berg SA; Uniken Venema SM; Reinink H; Hofmeijer J; Schonewille WJ; Miedema I; Fransen PSS; O Pruissen DM; Raaijmakers TWM; van Dijk GW; de Leeuw FE; van Vliet JA; Kwa VIH; Kerkhoff H; van 't Net A; Boomars R; Siegers A; Lok T; Caminada K; Esteve Cuevas LM; Visser MC; Zwetsloot CP; Boomsma JMF; Schipper MH; van Eijkelenburg RPJ; Berkhemer OA; Nieboer D; Lingsma HF; Emmer BJ; van Oostenbrugge RJ; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Nederkoorn PJ; van der Worp HB;
    Lancet Neurol; 2022 Nov; 21(11):971-981. PubMed ID: 36058230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
    Sandset EC; Bath PM; Boysen G; Jatuzis D; Kõrv J; Lüders S; Murray GD; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
    Lancet; 2011 Feb; 377(9767):741-50. PubMed ID: 21316752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.
    Potter J; Mistri A; Brodie F; Chernova J; Wilson E; Jagger C; James M; Ford G; Robinson T
    Health Technol Assess; 2009 Jan; 13(9):iii, ix-xi, 1-73. PubMed ID: 19208305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial.
    Robinson TG; Potter JF; Ford GA; Bulpitt CJ; Chernova J; Jagger C; James MA; Knight J; Markus HS; Mistri AK; Poulter NR;
    Lancet Neurol; 2010 Aug; 9(8):767-75. PubMed ID: 20621562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.
    Liu J; Li Y; Ge J; Yan X; Zhang H; Zheng X; Lu J; Li X; Gao Y; Lei L; Liu J; Li J;
    Lancet; 2024 Jul; 404(10449):245-255. PubMed ID: 38945140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial.
    Potter JF; Robinson TG; Ford GA; Mistri A; James M; Chernova J; Jagger C
    Lancet Neurol; 2009 Jan; 8(1):48-56. PubMed ID: 19058760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.
    RIGHT-2 Investigators
    Lancet; 2019 Mar; 393(10175):1009-1020. PubMed ID: 30738649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Early Intensive Blood Pressure Management After Thrombectomy: Protocol for a Randomized Controlled Clinical Trial (IDENTIFY).
    Zhang X; Hu F; Hao Z; Ye C; Wan J; Lu K; Pan R; Wu B
    Neurocrit Care; 2023 Feb; 38(1):196-203. PubMed ID: 36329307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure reduction in acute ischemic stroke according to time to treatment: a subgroup analysis of the China Antihypertensive Trial in Acute Ischemic Stroke trial.
    Xu T; Zhang Y; Bu X; Wang D; Sun Y; Chen CS; Wang J; Peng H; Ju Z; Peng Y; Xu T; Li Q; Geng D; Zhang J; Li D; Zhang F; Guo L; Wang X; Cui Y; Li Y; Ma D; Zhang D; Yang G; Gao Y; Yuan X; Chen J; He J;
    J Hypertens; 2017 Jun; 35(6):1244-1251. PubMed ID: 28169880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Blood Pressure Reduction in Acute Ischemic Stroke with Various Severities: A Subgroup Analysis of the CATIS Trial.
    Bu X; Li C; Zhang Y; Xu T; Wang D; Sun Y; Peng H; Xu T; Chen CS; Bazzano LA; Chen J; He J;
    Cerebrovasc Dis; 2016; 42(3-4):186-95. PubMed ID: 27110711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of early blood pressure reduction on cognitive function in patients with acute ischemic stroke.
    Bu X; Zhang Y; Bazzano LA; Xu T; Guo L; Wang X; Zhang J; Cui Y; Li D; Zhang F; Ju Z; Xu T; Chen CS; Chen J; He J
    Int J Stroke; 2016 Dec; 11(9):1009-1019. PubMed ID: 27412188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
    Gusev EI; Martynov MY; Nikonov AA; Shamalov NA; Semenov MP; Gerasimets EA; Yarovaya EB; Semenov AM; Archakov AI; Markin SS;
    Lancet Neurol; 2021 Sep; 20(9):721-728. PubMed ID: 34418399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.